Table 3. Included studies: perfusion assessment of gastric conduit during esophageal resection.
Study | Study design | ICG method (mg, IV) | Imaging system |
---|---|---|---|
Campbell et al. (10) | Retrospective | 5 (+ Doppler) | SPY Imaging Systema |
Dalton et al. (11) | Retrospective | 7.5 | PinPoint Systemb |
Ishige et al. (12) | Prospective | 1.25 | Olympusc |
Karampinis et al. (13) | Retrospective | 7.5 | PinPoint systemb |
Kitagawa et al. (14) | Retrospective | 5 | HyperEye Medical Systemd |
Kitagawa et al. (15) | Retrospective | 5 | HyperEye Medical Systemd |
Koyanagi et al. (16) | Prospective | 1.25 or 2.5 | Photodynamic Eyee |
Kubota et al. (17) | Prospective | 0.5 mg/kg | HyperEye Medical Systemd |
Kumagai et al. (18) | Prospective | 2.5 | Photodynamic Eyee |
Kumagai et al. (19) | Prospective | 2.5 | Photodynamic Eyee |
Murawa et al. (20) | Prospective | 25 | IC-VIEWf |
Noma et al. (21) | Retrospective | 12.5 | Photodynamic Eyee |
Ohi et al. (22) | Retrospective | 2.5 | Photodynamic Eyee |
Pacheco et al. (23) | Retrospective | NR | SPY Imaging Systema |
Rino et al. (24) | Prospective | 2.5 | Photodynamic Eyee |
Sarkaria et al. (25) | Prospective | 10 | SPY Imaging Systema |
Shimada et al. (26) | Retrospective | 2.5 | Photodynamic Eyee |
Schlottman et al. (27) | Prospective | 5 | IMAGE1 STORZg |
Yukaya et al. (28) | Prospective | 0.1 mg/kg | HyperEye Medical Systemd |
Zehetner et al. (29) | Prospective | 2.5 | SPY Imaging Systema |
a, Novadaq, Bonita Springs, FL, USA; b, Novadaq, Ontario, Canada; c, Olympus, Tokyo, Japan; d, Mizuho Ikakogyo Co., Ltd., Tokyo, Japan; e, Hamamatsu Photonics K.K, Hamamatsu, Japan; f, Pulsion Medical Systems, Munich, Germany; g, KARL STORZ Endoscopy-America, Inc., El Segundo, CA, United States of America. ICG, indocyanine green.